healthcare · FDA 21 CFR Part 11 · FDA 21 CFR Part 211 GMP · ICH E6 GCP
GxP / FDA 21 CFR Part 11 Pharma
Delete audit trail before inspection = automatic consent decree pattern
—FADP revised + FINMA AI expectations
Regulatory exposure — commonly overlooked:
QA releases batch on AI recommendation without hash-chained record — batch recall insurance void. · Swiss reinsurance hub — Munich Re, Swiss Re need asymmetry data with Swiss privacy compliance.
TAM / Exposure
Every GMP facility globally · Part 11 is law today
Insurance lines
Product recall · Pharma E&O
Exhibit authority
Switzerland FINMA AI Pack — GxP Electronic Records Integrity Pack
Global leaders
FDA · Merck · Lonza · Waters Corporation · ISPE · FINMA · Swiss Re · Munich Re
Deviation reports
AI flags GMP deviation — without receipt, QA cannot prove when they knew.
Annex 11 EU
European GMP requires same integrity — global pharma needs one primitive.
Recall insurance
Insurers deny recall claims when electronic records integrity violated.
[Switzerland] Reinsurance capital
Geneva/Zurich reinsurers price AI risk — actuarial feed jurisdiction-scoped.
[Switzerland] Banking secrecy
Swiss bank AI — FINMA documentation expectations exceed EU for trading AI.
[Text / Chat] Modality hook
Baseline — all frameworks apply to text decisions.
7 mandate layers (live)
Regulatory ClockCountdown to operative regulatory deadline — NAIC adoption, GSE mandate, EU transposition.Open →
Domain ClassifierIndustry-specific SAFE/CRISIS/VIOLATION with regulatory framework mapping.Open →
Exhibit / Filing PackRegulator-ready external validation — NAIC Exhibit D, Fannie QC, EU FRIA, FDA Part 11.Open →
Mandate RegistryEnroll deployers/insureds under vertical-specific governance mandate.Open →